Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders
- PMID: 20353544
- PMCID: PMC2873800
- DOI: 10.1186/gm143
Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders
Abstract
Diagnosing neurodegenerative diseases, monitoring their progression and assessing responses to treatments will all be aided by the identification of molecular markers of different stages of pathology. Protein biomarkers for HIV-associated neurocognitive disorders that have been discovered using proteomics include complement C3, soluble superoxide dismutase and a prostaglandin synthase. Metabolomics has not yet been widely used for biomarker discovery, but early work shows that it has great potential.
Similar articles
-
Proteomics and metabolomics of HIV-associated neurocognitive disorders: A systematic review.J Neurochem. 2021 May;157(3):429-449. doi: 10.1111/jnc.15295. Epub 2021 Jan 22. J Neurochem. 2021. PMID: 33421125
-
Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases.J Alzheimers Dis. 2005 Mar;8(4):377-86. doi: 10.3233/jad-2005-8407. J Alzheimers Dis. 2005. PMID: 16556969 Review.
-
Novel biomarkers for lysosomal storage disorders: Metabolomic and proteomic approaches.Clin Chim Acta. 2020 Oct;509:195-209. doi: 10.1016/j.cca.2020.06.028. Epub 2020 Jun 17. Clin Chim Acta. 2020. PMID: 32561345 Review.
-
Proteomic approaches in lung cancer biomarker development.Expert Rev Proteomics. 2009 Feb;6(1):27-42. doi: 10.1586/14789450.6.1.27. Expert Rev Proteomics. 2009. PMID: 19210125 Review.
-
Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.Electrophoresis. 2011 Apr;32(9):967-75. doi: 10.1002/elps.201000588. Epub 2011 Mar 30. Electrophoresis. 2011. PMID: 21449066 Review.
Cited by
-
Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms.Front Psychiatry. 2015 Jul 14;6:97. doi: 10.3389/fpsyt.2015.00097. eCollection 2015. Front Psychiatry. 2015. PMID: 26236243 Free PMC article. Review.
-
Nano-ART and NeuroAIDS.Drug Deliv Transl Res. 2016 Oct;6(5):452-72. doi: 10.1007/s13346-016-0293-z. Drug Deliv Transl Res. 2016. PMID: 27137528 Review.
-
Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.AIDS. 2017 Jun 19;31(10):1365-1378. doi: 10.1097/QAD.0000000000001503. AIDS. 2017. PMID: 28574961 Free PMC article.
-
A Pilot Investigation of the Association Between Vpr Amino Acid Substitutions and Peripheral Immune Marker Levels in People With Human Immunodeficiency Virus: Implications for Neurocognitive Impairment.Open Forum Infect Dis. 2024 Feb 27;11(3):ofae111. doi: 10.1093/ofid/ofae111. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38524224 Free PMC article.
-
Ibudilast reverses the decrease in the synaptic signaling protein phosphatidylethanolamine-binding protein 1 (PEBP1) produced by chronic methamphetamine intake in rats.Drug Alcohol Depend. 2015 Jul 1;152:15-23. doi: 10.1016/j.drugalcdep.2015.04.012. Epub 2015 Apr 30. Drug Alcohol Depend. 2015. PMID: 25962787 Free PMC article.
References
-
- Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–1799. doi: 10.1212/01.WNL.0000287431.88658.8b. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous